Peter Radovich's Net Worth

$3.96 Million

Estimate Recalculated Mar 27, 2024 07:49PM EST

Who is Peter Radovich?

Peter Radovich has an estimated net worth of $3.96 Million. This is based on reported shares across multiple companies, which include Rain Oncology Inc., Mirum Pharmaceuticals, Inc., and Global Blood Therapeutics, Inc..

SEC CIK

Peter Radovich's CIK is 0001650131

Past Insider Trading and Trends

2018 was Peter Radovich's most active year for acquiring shares with 9 total transactions. Peter Radovich's most active month to acquire stocks was the month of December. 2018 was Peter Radovich's most active year for disposing of shares, totalling 15 transactions. Peter Radovich's most active month to dispose stocks was the month of December. 2015 saw Peter Radovich paying a total of $250,000.00 for 12,500 shares, this is the most they've acquired in one year. In 2018 Peter Radovich cashed out on 103,861 shares for a total of $2,809,125.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Rain Oncology Inc. (RAIN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.80K
—
—
0
Jan 26
Form 4
—
0
—
—
0
Aug 9
Form 4
—
0
—
—
0
Jun 1
Form 4
∞
8.8K
—
—
8.8K
Apr 27
Form 3
—
0
—
—
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.815

PRESIDENT AND COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.92%
-4.30K
$25.80
-$111,017.40
29.01K
Mar 25
Form 4
-3.97%
-1.38K
$20.62
-$28,438.15
33.32K
Jan 9
Form 4
-4.91%
-1.79K
$26.19
-$46,883.14
34.7K
Feb 2
Form 4
—
0
—
—
0
Jan 23
Form 4
-3.72%
-1.41K
$28.03
-$39,472.58
36.48K
Jan 8
Form 4
+0.58%
218
$22.29
$4,858.57
37.89K
Nov 10
Form 4
-3.64%
-1.43K
$25.65
-$36,546.40
37.67K
Jul 3
Form 4
+2.54%
968
$16.92
$16,381.95
39.1K
May 10
Form 4
+60.95%
14.44K
—
—
38.13K
Jan 31
Form 4
+1.25%
292
$17.05
$4,978.89
23.69K
Nov 10
Form 4
+5.26%
1.17K
$13.57
$15,858.65
23.4K
May 10
Form 4
+81.76%
10K
—
—
22.23K
Jan 6
Form 4
+8.50%
958
$13.52
$12,947.37
12.23K
Nov 10
Form 4
+149.84%
6.76K
$19.26
-$26,264.50
11.27K
Sep 29 - Oct 1
Form 4
+28.69%
1.01K
$14.62
$14,707.72
4.51K
May 10
Form 4
—
0
—
—
0
Jan 7
Form 4
+32.55%
861
$15.27
$13,144.03
3.51K
Nov 10
Form 4
—
0
—
—
0
Apr 28
Form 3
—
0
—
—
0
No matching records found

Global Blood Therapeutics, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.04%
806
$62.30
-$49,466.20
8.83K
Feb 14
Form 4
+47.52%
2.2K
$58.43
-$140,469.00
6.82K
Scheduled
Jan 31 - Feb 1
Form 4
+29.04%
1.04K
$58.15
-$32,564.00
4.62K
Jan 24
Form 4
—
0
$30.81
-$1,751,700.00
3.58K
Scheduled
Jan 23
Form 4
+33.42%
897
$52.10
-$36,626.30
3.58K
Jan 16
Form 4
—
0
$25.81
-$725,850.00
2.68K
Scheduled
Jan 10
Form 4
-100.00%
-12.50K
$35.00
-$437,500.00
0
Scheduled
Oct 30
Form 4
-47.31%
-2.41K
$30.00
-$72,300.00
2.68K
Scheduled
Aug 31
Form 4
—
0
—
—
0
Aug 11
Form 4
+58.10%
1.87K
$25.10
-$28,312.80
5.09K
Aug 1
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Mar 10
Form 4
+9.80%
1.23K
$16.09
$19,710.25
13.72K
Feb 1
Form 4
∞
12.5K
$20.00
$250,000.00
12.5K
Aug 17
Form 3
—
0
—
—
0
No matching records found